---
name: Swiss BioQuant AG
slug: swissbioquant
site: cro
website_domain: swissbioquant.com
summary: Bioanalytical CRO offering LC-MS/MS and ligand-binding assay development, validation, and sample analysis for small and large molecules. Work runs in a 21 CFR Part 11 compliant environment, with qPCR support for gene therapy bioanalysis.
tagline: LC-MS/MS and ligand-binding bioanalysis for small and large molecules
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: 
tier2_domain_verified: false
updated_at: 2026-10-25T07:02:01.659Z
services_count: 6
modalities_count: 6
indications_count: 0
locations_count: 0
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Swiss BioQuant AG

LC-MS/MS and ligand-binding bioanalysis for small and large molecules

Listed on cro.directory.

## Summary

Bioanalytical CRO offering LC-MS/MS and ligand-binding assay development, validation, and sample analysis for small and large molecules. Work runs in a 21 CFR Part 11 compliant environment, with qPCR support for gene therapy bioanalysis.

## Services

- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Biomarker Assays
- Immunogenicity Assays (ADA / NAb)
- In Vivo PK / PD Studies

## Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Peptide
- Biologics (Other)
- Gene Therapy
- Cell Therapy

## Long description

## Bioanalysis for small and large molecules

Swiss BioQuant describes itself as a bioanalytical contract research organization focused on LC-MS/MS and ligand-binding assays. Services cover method development, validation, and sample analysis for both small and large molecules in non-clinical and clinical studies.

- **LC-MS/MS:** High-performance liquid chromatography coupled with tandem mass spectrometry for quantitative analysis in complex biological matrices.
- **Ligand-binding assays:** Used for proteins, peptides, and antibodies in pharmacokinetic (PK) and pharmacodynamic (PD) studies.
- **Biomarker and metabolite determination:** Drug, metabolite, and biomarker determination in preclinical and clinical studies.
- **Cell and gene therapy bioanalysis:** qPCR for nucleic acid quantification, including vector copy number and gene expression.

## Quality and compliance

The company states that its work is performed in a 21 CFR Part 11 compliant environment. It also reports a validated electronic archiving system and an automated data evaluation and reporting system. Its test facility has been inspected by Swissmedic since 2008, and the excerpts describe GLP compliance under the Swiss Ordinance relating to Good Laboratory Practice.

## Experience

The company cites more than 20 years of LC-MS/MS and ELISA bioanalysis experience, with work supporting new drug entities and generics applications.

## Related companies

- [BioAgilytix](/companies/bioagilytix) (Bioanalysis, LC-MS Bioanalysis (Small Molecule)) — [Compare](/compare/bioagilytix/swissbioquant)
- [Celerion](/companies/celerion) (Bioanalysis, LC-MS Bioanalysis (Small Molecule)) — [Compare](/compare/celerion/swissbioquant)
- [KCAS Bio](/companies/kcasbio) (Bioanalysis, LC-MS Bioanalysis (Small Molecule)) — [Compare](/compare/kcasbio/swissbioquant)
- [Fog City Bio](/companies/fogcitybio) (Bioanalysis, Ligand-Binding Bioanalysis (Large Molecule)) — [Compare](/compare/fogcitybio/swissbioquant)
- [SoCal Biosciences, Inc.](/companies/socalbiosci) (Bioanalysis, LC-MS Bioanalysis (Small Molecule)) — [Compare](/compare/socalbiosci/swissbioquant)
- [Aragen Life Sciences](/companies/aragen) (Bioanalysis, LC-MS Bioanalysis (Small Molecule)) — [Compare](/compare/aragen/swissbioquant)
- [Aliri Bioanalysis](/companies/aliribio) (Bioanalysis, LC-MS Bioanalysis (Small Molecule)) — [Compare](/compare/aliribio/swissbioquant)
- [PPD](/companies/ppd) (Bioanalysis, LC-MS Bioanalysis (Small Molecule)) — [Compare](/compare/ppd/swissbioquant)

_Profile last updated: 2026-10-25T07:02:01.659Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.